Suitability Rules News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Suitability rules. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Suitability Rules Today - Breaking & Trending Today

FINRA and Social Media: 7 Tips to Stay Compliant

FINRA rules apply to social media like any other communications medium. Learn how to build a compliant strategy and avoid common violation risks. ....

United States , Hootsuite Proofpoint , Exchange Commission , Advertising Regulation Department , Financial Industry Regulatory Authority , Media Tool For Financial Services , Investor Education Foundation , Financial Industry Regulatory , Media Tool , Financial Services , Education Foundation , Cautionary Action , General Securities , Regulatory Notice , Sanctions Guidelines , Suitability Rules , Hootsuite Amplify ,

Brussels Regulatory Brief: February 2021 | K&L Gates LLP

ANTITRUST AND COMPETITION
The European Commission Accepts Commitments from a Pharma Company to Stop Its Excessive Prices
On 15 May 2017, the European Commission (Commission) announced that it had opened formal proceedings to investigate whether a pharma company abused its dominant position by charging excessive prices for certain off-patent cancer medicines, in breach of EU antitrust rules.
The Commission found that the pharma company has consistently earned very high profits from its sale of these cancer medicines in Europe, both in absolute terms and when compared with the profit levels of similar companies in the industry. In fact, the company’s prices exceeded its relevant costs by almost 300 percent on average without the Commission’s investigation revealing any justifications for the company’s high-profit levels. ....

Steven Maijoor , Council Of The European Union , Commission The Regulatory Technical Standards , Commission Commitment Decision , European Commission , Pharma Company To Stop Its Excessive Prices , Kl Gates , European Commission Prolongs , European Parliament , European Commission Accepts Commitments , Dutch Authority For Consumers , European Union , Committee Of The European Supervisory Authorities , Pharma Company , Stop Its Excessive , European Economic Area , Commitment Decision , Paid Temporary , Markets Publishes Study , Dutch Authority , Digital Markets Act , Markets Act , Report From , Supervisory Authorities Agree , Regulatory Technical Standards , Key Information ,

Brussels Regulatory Brief: February 2021

Brussels Regulatory Brief: February 2021
Friday, March 12, 2021
The European Commission Accepts Commitments from a Pharma Company to Stop Its Excessive Prices
On 15 May 2017, the European Commission (Commission) announced that it had opened formal proceedings to investigate whether a pharma company abused its dominant position by charging excessive prices for certain off-patent cancer medicines, in breach of EU antitrust rules.
The Commission found that the pharma company has consistently earned very high profits from its sale of these cancer medicines in Europe, both in absolute terms and when compared with the profit levels of similar companies in the industry. In fact, the company’s prices exceeded its relevant costs by almost 300 percent on average without the Commission’s investigation revealing any justifications for the company’s high-profit levels. ....

Steven Maijoor , Council Of The European Union , Commission Commitment Decision , European Commission , Pharma Company To Stop Its Excessive Prices , European Commission Prolongs , European Parliament , European Commission Accepts Commitments , Dutch Authority For Consumers , European Union , Committee Of The European Supervisory Authorities , Pharma Company , Stop Its Excessive , European Economic Area , Commitment Decision , Paid Temporary , Markets Publishes Study , Dutch Authority , Digital Markets Act , Markets Act , Report From , Supervisory Authorities Agree , Regulatory Technical Standards , Key Information , Joint Committee , European Supervisory Authorities ,